Home News

2017 Results presentation

Operating income, growth figures, profitability and how our products have behaved.

Tue, 20/02/2018 - 12:50 1 min

Operating income, growth figures, profitability and how our products have behaved.

Download related document
No votes yet
 
Related
ROVI increases its fill-finish capacity for the COVID-19 Vaccine Moderna
ROVI increases its fill-finish capacity for the COVID-19 Vaccine Moderna
Laboratorios Farmacéuticos Rovi, S.A. (BME: ROVI), a pan-European pharmaceutical company specializing and engaging in the research,...
2 min
29/04/2021
ROVI participates in the manufacture of the active substance of Moderna’s COVID...
Laboratorios Farmacéuticos Rovi, S.A. (BME: ROVI), a pan-European pharmaceutical company specializing and engaging in the research,...
2 min
12/04/2021
Full Year 2020 Results Press Release
0 min
24/02/2021